Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

ME Hagendijk; S van der Schans; C Boersma; MJ Postma; S van der Pol

doi:10.1007/s10198-021-01303-2

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

ME Hagendijk, S van der Schans, C Boersma, MJ Postma, S van der Pol

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	991-999
Number of pages	9
Journal	European Journal of Health Economics
Volume	22
Issue number	6
DOIs	https://doi.org/10.1007/s10198-021-01303-2
Publication status	Published - Aug 2021

Keywords

Economic evaluation
Lu-177-DOTATATE
Lutetium-Octreotate
Neuroendocrine tumour
Octreotide long-acting release

Access to Document

10.1007/s10198-021-01303-2Licence: CC BY

Cite this

@article{25af25d7e21948a08333eb4ce9d2a333,

title = "Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands",

keywords = "Economic evaluation, Lu-177-DOTATATE, Lutetium-Octreotate, Neuroendocrine tumour, Octreotide long-acting release",

author = "ME Hagendijk and {van der Schans}, S and C Boersma and MJ Postma and {van der Pol}, S",

year = "2021",

month = aug,

doi = "10.1007/s10198-021-01303-2",

language = "English",

volume = "22",

pages = "991--999",

journal = "European Journal of Health Economics",

issn = "1618-7598",

publisher = "Springer",

number = "6",

}

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands. / Hagendijk, ME; van der Schans, S; Boersma, C et al.
In: European Journal of Health Economics, Vol. 22, No. 6, 08.2021, p. 991-999.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

AU - Hagendijk, ME

AU - van der Schans, S

AU - Boersma, C

AU - Postma, MJ

AU - van der Pol, S

PY - 2021/8

Y1 - 2021/8

KW - Economic evaluation

KW - Lu-177-DOTATATE

KW - Lutetium-Octreotate

KW - Neuroendocrine tumour

KW - Octreotide long-acting release

U2 - 10.1007/s10198-021-01303-2

DO - 10.1007/s10198-021-01303-2

M3 - Article

C2 - 33829344

SN - 1618-7598

VL - 22

SP - 991

EP - 999

JO - European Journal of Health Economics

JF - European Journal of Health Economics

IS - 6

ER -